Primary Site >> Liver Cancer

Gene >> RICTOR

Journal: Gastroenterology. 2008 Dec;135(6):1972-83, 1983.e1-11.
Title: Pivotal role of mTOR signaling in hepatocellular carcinoma.
Author: Villanueva, Augusto|Chiang, Derek Y|Newell, Pippa|Peix, Judit|Thung, Swan|Alsinet, Clara|Tovar, Victoria|Roayaie, Sasan|Minguez, Beatriz|Sole, Manel|Battiston, Carlo|Van Laarhoven, Stijn|Fiel, Maria I|Di Feo, Analisa|Hoshida, Yujin|Yea, Steven|Toffanin, S
PMID: 18929564
Journal: PLoS One. 2013 Nov 27;8(11):e82346.
Title: Branched chain amino acid suppresses hepatocellular cancer stem cells through the activation of mammalian target of rapamycin.
Author: Nishitani, Shinobu|Horie, Mayumi|Ishizaki, Sonoko|Yano, Hirohisa
PMID: 24312415
Journal: Dig Dis Sci. 2015 Apr;60(4):919-28.
Title: Influence of Rictor and Raptor Expression of mTOR Signaling on Long-Term Outcomes of Patients with Hepatocellular Carcinoma.
Author: Kaibori, Masaki|Shikata, Nobuaki|Sakaguchi, Tatsuma|Ishizaki, Morihiko|Matsui, Kosuke|Iida, Hiroya|Tanaka, Yoshito|Miki, Hirokazu|Nakatake, Richi|Okumura, Tadayoshi|Tokuhara, Katsuji|Inoue, Kentaro|Wada, Jouji|Oda, Michio|Nishizawa, Mikio|Kon, Masanori
PMID: 25371154
Journal: Cancer Res. 2015 Apr 1;75(7):1470-81.
Title: CYP3A5 Functions as a Tumor Suppressor in Hepatocellular Carcinoma by Regulating mTORC2/Akt Signaling.
Author: Jiang, Feng|Chen, Lei|Yang, Ying-Cheng|Wang, Xian-Ming|Wang, Ruo-Yu|Li, Liang|Wen, Wen|Chang, Yan-Xin|Chen, Cai-Yang|Tang, Jing|Liu, Gao-Mi-Yang|Huang, Wen-Tao|Xu, Lin|Wang, Hong-Yang
PMID: 25649767
Journal: J Hepatol. 2016 Feb;64(2):333-341.
Title: Inactivation of fatty acid synthase impairs hepatocarcinogenesis driven by AKT in mice and humans.
Author: Li, Lei|Pilo, Giulia M|Li, Xiaolei|Cigliano, Antonio|Latte, Gavinella|Che, Li|Joseph, Christy|Mela, Marta|Wang, Chunmei|Jiang, Lijie|Ribback, Silvia|Simile, Maria M|Pascale, Rosa M|Dombrowski, Frank|Evert, Matthias|Semenkovich, Clay F|Chen, Xin|Calvisi, D
PMID: 26476289
Journal: Tumour Biol. 2017 Feb;39(2):1010428317694313.
Title: MicroRNA-185 induces potent autophagy via AKT signaling in hepatocellular carcinoma.
Author: Zhou, Li|Liu, Shunai|Han, Ming|Feng, Shenghu|Liang, Jinqiu|Li, Zhongshu|Li, Yaru|Lu, Hongping|Liu, Ting|Ma, Yanhua|Cheng, Jun
PMID: 28240051
Journal: Oncol Rep. 2018 Feb;39(2):843-850.
Title: Survival pathway of cholangiocarcinoma via AKT/mTOR signaling to escape RAF/MEK/ERK pathway inhibition by sorafenib.
Author: Yokoi, Kenta|Kobayashi, Akira|Motoyama, Hiroaki|Kitazawa, Masato|Shimizu, Akira|Notake, Tsuyoshi|Yokoyama, Takahide|Matsumura, Tomio|Takeoka, Michiko|Miyagawa, Shin-Ichi
PMID: 29251327
Journal: Exp Mol Med. 2018 Jan 5;50(1):e417.
Title: Loss of Pten synergizes with c-Met to promote hepatocellular carcinoma development via mTORC2 pathway.
Author: Xu, Zhong|Hu, Junjie|Cao, Hui|Pilo, Maria G|Cigliano, Antonio|Shao, Zixuan|Xu, Meng|Ribback, Silvia|Dombrowski, Frank|Calvisi, Diego F|Chen, Xin
PMID: 29303510